Intestinal calcium absorption in exogenous hypercortisonism. Role of 25 hydroxyvitamin D and corticosteroid dose

R. G. Klein, S. B. Arnaud, John Christopher G. Gallagher, H. F. Deluca, B. L. Riggs

Research output: Contribution to journalArticle

264 Citations (Scopus)

Abstract

Pharmacologic doses of corticosteroids impair intestinal calcium absorption and contribute to negative calcium balance. However, the relation between the impaired calcium absorption and a possible defect in the conversion of vitamin D to its physiologically active form, 1,25-dihydrovitamin D, is unknown. The fractional calcium absorption (double-isotope method, 100-mg carrier) and the serum 25-hydroxyvitamin D (25-OH-D) (Haddad method) level were compared in 27 patients receiving pharmacologic doses of prednisone with 27 age-, sex-, and season-matched normal subjects. In patients receiving high daily doses of prednisone (15-100 mg/day), calcium absorption (P3 (0.4 μg daily for 7 days) to patients receiving high-dose corticosteroids led to an increase in calcium absorption in all patients. These results suggest that calcium malabsorption in the corticosteroid-treated patients is due to a dose-related abnormality of vitamin D metabolism and not to a direct effect of corticosteroids on depressing transmucosal intestinal absorption of calcium.

Original languageEnglish
Pages (from-to)253-259
Number of pages7
JournalJournal of Clinical Investigation
Volume60
Issue number1
StatePublished - 1977
Externally publishedYes

Fingerprint

Intestinal Absorption
Adrenal Cortex Hormones
Calcium
Prednisone
Vitamin D
25-hydroxyvitamin D
Isotopes
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25 hydroxyvitamin D and corticosteroid dose. / Klein, R. G.; Arnaud, S. B.; Gallagher, John Christopher G.; Deluca, H. F.; Riggs, B. L.

In: Journal of Clinical Investigation, Vol. 60, No. 1, 1977, p. 253-259.

Research output: Contribution to journalArticle

@article{0752a412567b4326a0dd86dac7376437,
title = "Intestinal calcium absorption in exogenous hypercortisonism. Role of 25 hydroxyvitamin D and corticosteroid dose",
abstract = "Pharmacologic doses of corticosteroids impair intestinal calcium absorption and contribute to negative calcium balance. However, the relation between the impaired calcium absorption and a possible defect in the conversion of vitamin D to its physiologically active form, 1,25-dihydrovitamin D, is unknown. The fractional calcium absorption (double-isotope method, 100-mg carrier) and the serum 25-hydroxyvitamin D (25-OH-D) (Haddad method) level were compared in 27 patients receiving pharmacologic doses of prednisone with 27 age-, sex-, and season-matched normal subjects. In patients receiving high daily doses of prednisone (15-100 mg/day), calcium absorption (P3 (0.4 μg daily for 7 days) to patients receiving high-dose corticosteroids led to an increase in calcium absorption in all patients. These results suggest that calcium malabsorption in the corticosteroid-treated patients is due to a dose-related abnormality of vitamin D metabolism and not to a direct effect of corticosteroids on depressing transmucosal intestinal absorption of calcium.",
author = "Klein, {R. G.} and Arnaud, {S. B.} and Gallagher, {John Christopher G.} and Deluca, {H. F.} and Riggs, {B. L.}",
year = "1977",
language = "English",
volume = "60",
pages = "253--259",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Intestinal calcium absorption in exogenous hypercortisonism. Role of 25 hydroxyvitamin D and corticosteroid dose

AU - Klein, R. G.

AU - Arnaud, S. B.

AU - Gallagher, John Christopher G.

AU - Deluca, H. F.

AU - Riggs, B. L.

PY - 1977

Y1 - 1977

N2 - Pharmacologic doses of corticosteroids impair intestinal calcium absorption and contribute to negative calcium balance. However, the relation between the impaired calcium absorption and a possible defect in the conversion of vitamin D to its physiologically active form, 1,25-dihydrovitamin D, is unknown. The fractional calcium absorption (double-isotope method, 100-mg carrier) and the serum 25-hydroxyvitamin D (25-OH-D) (Haddad method) level were compared in 27 patients receiving pharmacologic doses of prednisone with 27 age-, sex-, and season-matched normal subjects. In patients receiving high daily doses of prednisone (15-100 mg/day), calcium absorption (P3 (0.4 μg daily for 7 days) to patients receiving high-dose corticosteroids led to an increase in calcium absorption in all patients. These results suggest that calcium malabsorption in the corticosteroid-treated patients is due to a dose-related abnormality of vitamin D metabolism and not to a direct effect of corticosteroids on depressing transmucosal intestinal absorption of calcium.

AB - Pharmacologic doses of corticosteroids impair intestinal calcium absorption and contribute to negative calcium balance. However, the relation between the impaired calcium absorption and a possible defect in the conversion of vitamin D to its physiologically active form, 1,25-dihydrovitamin D, is unknown. The fractional calcium absorption (double-isotope method, 100-mg carrier) and the serum 25-hydroxyvitamin D (25-OH-D) (Haddad method) level were compared in 27 patients receiving pharmacologic doses of prednisone with 27 age-, sex-, and season-matched normal subjects. In patients receiving high daily doses of prednisone (15-100 mg/day), calcium absorption (P3 (0.4 μg daily for 7 days) to patients receiving high-dose corticosteroids led to an increase in calcium absorption in all patients. These results suggest that calcium malabsorption in the corticosteroid-treated patients is due to a dose-related abnormality of vitamin D metabolism and not to a direct effect of corticosteroids on depressing transmucosal intestinal absorption of calcium.

UR - http://www.scopus.com/inward/record.url?scp=0017647834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017647834&partnerID=8YFLogxK

M3 - Article

C2 - 874087

AN - SCOPUS:0017647834

VL - 60

SP - 253

EP - 259

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -